Skip to content

Epidemiology of Mucormycosis in a Thai Tertiary-Care Hospital, King Chulalongkorn Memorial Hospital, Bangkok, during 2006-2016

Epidemiology of Mucormycosis in a Thai Tertiary-Care Hospital, King Chulalongkorn Memorial Hospital, Bangkok, during 2006-2016

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
TCTR
Registry ID
TCTR20190121002
Enrollment
Unknown
Registered
2019-01-21
Start date
2018-02-24
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

&#45

Interventions

These patients with mucormycosis were then classified as proven&#44
probable&#44
and possible mucormycosis according to EORTC/MSG criteria. Proven mucormycosis was defined as a positive finding in the histopathologic or cytopathologic or direct microscopic examination with Gomoriâ
Other,Other
Patients with mucormycosis,

Sponsors

Grants for Development of New Faculty Staff, Ratchadaphiseksomphot Endowment Fund, Chulalongkorn Uni
Lead Sponsor

Eligibility

Sex/Gender
All
Age
0 Years to No maximum

Inclusion criteria

Inclusion criteria: These patients with mucormycosis were then classified as proven, probable, and possible mucormycosis according to EORTC/MSG criteria. Proven mucormycosis was defined as a positive finding in the histopathologic or cytopathologic or direct microscopic examination with Gomori’s methenamine silver stain of the tissue or a positive culture from sterile sites. Probable mucormycosis required at least a host factor and a microbiological criterion and a clinical criterion according to EORTC/MSG criteria. Possible mucormycosis could be categorized by the proper host factors together with clinical criteria supporting the infection without the mycological support according to EORTC/MSG criteria.

Exclusion criteria

Exclusion criteria: Patients with other infections that are not mucormycosis.

Design outcomes

Primary

MeasureTime frame
Demographic data of patient with mucormycosis 10 years Number, percentage

Secondary

MeasureTime frame
Treatment and mortality rate of patients with mucormycosis 10 years mortality rate, percentage

Countries

Thailand

Contacts

Public ContactArsa Thammahong

Chulalongkorn University

mee009@gmail.com+6622564132

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026